Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GENTEX CORP Director's Dealing 2023

Feb 21, 2023

30893_dirs_2023-02-21_3376f2ae-dc55-4125-bfe8-3394d2a4f89b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GENTEX CORP (GNTX)
CIK: 0000355811
Period of Report: 2023-02-16

Reporting Person: Ryan Scott P (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-16 Common Stock A 6666.00 $0.00 Acquired 24956.00 Direct
2023-02-21 Common Stock A 5570.00 $0.00 Acquired 30526.00 Direct
2023-02-21 Common Stock S 5570.00 $28.2919 Disposed 24956.00 Direct
2023-02-21 Common Stock S 4325.00 $28.2919 Disposed 20631.00 Direct

Footnotes

F1: These shares vest 100% three years from grant award date.

F2: 5,570 shares are performance based shares where the total number of shares granted were based on long term performance incentives.

F3: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.

F4: This transaction was executed in multiple trades at prices ranging from $28.02 to $28.60. The price reported above reflects the weighted average price.